A Promising Approach: Magnetic Nanosystems for Alzheimer's Disease Theranostics

Area of Science:

• Neuroscience and Nanotechnology
• Biomedical Engineering
• Pharmacology

Background:

• Alzheimer's disease (AD) is a leading cause of dementia, with its unclear etiology and the blood-brain barrier (BBB) hindering effective treatments.
• Current therapeutic strategies for CNS disorders face challenges due to limited drug penetration into the brain and potential side effects.
• Nanotechnology offers multifunctional platforms, with nanoparticles (NPs) showing potential for AD theranostics.

Purpose of the Study:

• To review magnetic nanoparticle (MNP)-based systems for Alzheimer's disease (AD) theranostics.
• To highlight the potential of surface-modified MNPs for neuro-targeted diagnosis and treatment.
• To explore MNPs as a dual platform for molecular imaging and drug delivery across the BBB.

Main Methods:

• Review of MNP-based systems for CNS drug delivery and molecular imaging.
• Discussion of surface functionalization strategies to enhance BBB transport.
• Integration of MNP physical properties with surface modifications for targeted neurotheranostics.

Main Results:

• MNPs can function as MRI contrast agents and drug delivery vehicles.
• Surface functionalization of MNPs influences interaction with brain endothelial cells, facilitating BBB crossing.
• Multifunctional MNPs represent a novel strategy for neuro-targeted AD theranostics.

Conclusions:

• MNP-based systems offer a promising dual approach for diagnosing and treating neurodegenerative disorders like AD.
• Surface modifications are crucial for optimizing MNP interaction with the BBB and enhancing brain penetration.
• Further advancements in MNP technology hold significant potential for future AD theranostics.